Steris | STE - Gross Profit On Sales


Steris reported $655.5M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
3M USD 2.46B 398M Mar/2026
Accuray USD 41.89M 7.42M Dec/2024
Avanos Medical USD 94.2M 8.2M Mar/2026
Baxter International USD 891M 314M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Boston Scientific USD 3.61B 64M Mar/2026
CONMED USD 183.45M 34.84M Mar/2026
Cooper Companies USD 735.4M 40.2M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
Ecolab USD 1.78B 65.5M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Fortive USD 675.5M 33.4M Mar/2026
Getinge SEK 5.05B 1.5B Dec/2024
Globus Medical USD 496.26M 39.69M Mar/2026
Haemonetics USD 202.39M 7.64M Dec/2025
Idexx Laboratories USD 722.74M 64.62M Mar/2026
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
J&J USD 17.24B 642M Mar/2026
Olympus JPY 192.76B 27.86B Mar/2026
Orthofix International USD 153.28M 4.76M Dec/2025
Owens Minor USD 272.05M 20.92M Dec/2025
ResMed USD 890.98M 12.26M Mar/2026
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 3.81B 675M Mar/2026
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.43M 21K Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025